Overview

Gender

female

Investor Type

Investment Partner

Mara was the President and Chief Executive Officer of Ventana Medical Systems, the Tissue Diagnostics Division of the Roche Group.

While at Ventana, she led the company to increased market leadership worldwide and primacy in companion diagnostics. Previously, Mara spent twelve years at Genzyme Corporation (now part of Sanofi) where she was the President of Genzyme Genetics and Genzyme Pharmaceuticals. She was also the founder and chief executive officer of On-Q-ity, a circulating tumour cells company.

Mara is co-founder of EPEMED (European Personalized Medicine Association) and the International School of Biomedical Diagnostics at Arizona State University and Dublin City University, the only school dedicated to the study of diagnostics as an independent discipline. She is a fellow of the American Institute for Medical and Biological Engineering.

Mara is the Chief Executive Officer of Health Catalysts, Executive Chairman of GenePeeks Inc. Director of Safeguard Scientifics Inc., Director of Castle Biosciences, a Director of Blue Cross Blue Shield Arizona, Director of SenesTech Inc,. a Director of CA Therapeutics and is on the non-fiduciary advisory boards of ProMIS Neurosciences, Inc., Slone Partners and Greybird Ventures.

Mara has considerable international experience in the biotechnology and diagnostics industries with small and large, public and private companies. Mara’s specific focus areas are in her operational expertise including acquisition integration, global manufacturing, quality systems and strategic marketing. Her knowledge of the diagnostics industry is helpful in establishing Abcam’s business in this sector.